22nd Century Group, Inc.
Biotech firm using plant science to create very low nicotine tobacco for harm reduction.
XXII | NDAQ
Overview
Corporate Details
- ISIN(s):
- US90137F1030
- LEI:
- Country:
- United States of America
- Address:
- 8560 MAIN STREET, 14221 WILLIAMSVILLE
- Website:
- https://www.xxiicentury.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of tobacco products
Description
22nd Century Group, Inc. is an agricultural biotechnology company focused on tobacco harm reduction and utilizing plant science to improve health and wellness. The company employs proprietary technology to modify the genetic makeup of tobacco plants, primarily to produce very low nicotine content (VLNC) tobacco. Its flagship product line includes cigarettes containing 95% less nicotine than conventional brands, offering adult smokers a reduced-nicotine alternative. The company's mission is to disrupt the tobacco industry by providing products that help reduce nicotine consumption and dependence. Its research and development efforts also extend to the hemp/cannabis and hops industries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all 22nd Century Group, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 22nd Century Group, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 22nd Century Group, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
